Antihemophilic Factor (Recombinant [Fc Fusion Protein]) and Lenvima
Determining the interaction of Antihemophilic Factor (Recombinant [Fc Fusion Protein]) and Lenvima and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Lenvima (14 MG Daily Dose)
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Lenvima (18 MG Daily Dose)
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Lenvima (20 MG Daily Dose)
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Lenvima (24 MG Daily Dose)
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Lenvima (8 MG Daily Dose)
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Lenvima 10 MG Daily Dose
- Lenvima-Antihemophilic Factor (Recombinant [Pegylated-aucl])
- Lenvima-Antihemophilic Factor (Recombinant [Pegylated])
- Lenvima-Antihemophilic Factor (Recombinant [Pegylated]) Injection
- Lenvima-Antihemophilic Factor (Recombinant [Porcine Sequence])
- Lenvima-Antihemophilic Factor (Recombinant) (Advate)
- Lenvima-Antihemophilic Factor (Recombinant) (Afstyla)